Cargando…
Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197829/ https://www.ncbi.nlm.nih.gov/pubmed/37208774 http://dx.doi.org/10.1186/s40644-023-00548-9 |
| _version_ | 1785044624631398400 |
|---|---|
| author | Sjöholm, Therese Korenyushkin, Alexander Gammelgård, Gustav Sarén, Tina Lövgren, Tanja Loskog, Angelica Essand, Magnus Kullberg, Joel Enblad, Gunilla Ahlström, Håkan |
| author_facet | Sjöholm, Therese Korenyushkin, Alexander Gammelgård, Gustav Sarén, Tina Lövgren, Tanja Loskog, Angelica Essand, Magnus Kullberg, Joel Enblad, Gunilla Ahlström, Håkan |
| author_sort | Sjöholm, Therese |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10197829 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101978292023-05-20 Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy Sjöholm, Therese Korenyushkin, Alexander Gammelgård, Gustav Sarén, Tina Lövgren, Tanja Loskog, Angelica Essand, Magnus Kullberg, Joel Enblad, Gunilla Ahlström, Håkan Cancer Imaging Correction BioMed Central 2023-05-19 /pmc/articles/PMC10197829/ /pubmed/37208774 http://dx.doi.org/10.1186/s40644-023-00548-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Sjöholm, Therese Korenyushkin, Alexander Gammelgård, Gustav Sarén, Tina Lövgren, Tanja Loskog, Angelica Essand, Magnus Kullberg, Joel Enblad, Gunilla Ahlström, Håkan Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy |
| title | Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy |
| title_full | Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy |
| title_fullStr | Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy |
| title_full_unstemmed | Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy |
| title_short | Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy |
| title_sort | correction to: whole body fdg pet/mr for progression free and overall survival prediction in patients with relapsed/refractory large b-cell lymphomas undergoing car t-cell therapy |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197829/ https://www.ncbi.nlm.nih.gov/pubmed/37208774 http://dx.doi.org/10.1186/s40644-023-00548-9 |
| work_keys_str_mv | AT sjoholmtherese correctiontowholebodyfdgpetmrforprogressionfreeandoverallsurvivalpredictioninpatientswithrelapsedrefractorylargebcelllymphomasundergoingcartcelltherapy AT korenyushkinalexander correctiontowholebodyfdgpetmrforprogressionfreeandoverallsurvivalpredictioninpatientswithrelapsedrefractorylargebcelllymphomasundergoingcartcelltherapy AT gammelgardgustav correctiontowholebodyfdgpetmrforprogressionfreeandoverallsurvivalpredictioninpatientswithrelapsedrefractorylargebcelllymphomasundergoingcartcelltherapy AT sarentina correctiontowholebodyfdgpetmrforprogressionfreeandoverallsurvivalpredictioninpatientswithrelapsedrefractorylargebcelllymphomasundergoingcartcelltherapy AT lovgrentanja correctiontowholebodyfdgpetmrforprogressionfreeandoverallsurvivalpredictioninpatientswithrelapsedrefractorylargebcelllymphomasundergoingcartcelltherapy AT loskogangelica correctiontowholebodyfdgpetmrforprogressionfreeandoverallsurvivalpredictioninpatientswithrelapsedrefractorylargebcelllymphomasundergoingcartcelltherapy AT essandmagnus correctiontowholebodyfdgpetmrforprogressionfreeandoverallsurvivalpredictioninpatientswithrelapsedrefractorylargebcelllymphomasundergoingcartcelltherapy AT kullbergjoel correctiontowholebodyfdgpetmrforprogressionfreeandoverallsurvivalpredictioninpatientswithrelapsedrefractorylargebcelllymphomasundergoingcartcelltherapy AT enbladgunilla correctiontowholebodyfdgpetmrforprogressionfreeandoverallsurvivalpredictioninpatientswithrelapsedrefractorylargebcelllymphomasundergoingcartcelltherapy AT ahlstromhakan correctiontowholebodyfdgpetmrforprogressionfreeandoverallsurvivalpredictioninpatientswithrelapsedrefractorylargebcelllymphomasundergoingcartcelltherapy |